144 related articles for article (PubMed ID: 24094238)
1. A review of the JR blood group system.
Castilho L; Reid ME
Immunohematology; 2013; 29(2):63-8. PubMed ID: 24094238
[TBL] [Abstract][Full Text] [Related]
2. The JR blood group system (ISBT 032): molecular characterization of three new null alleles.
Hue-Roye K; Lomas-Francis C; Coghlan G; Zelinski T; Reid ME
Transfusion; 2013 Jul; 53(7):1575-9. PubMed ID: 23066723
[TBL] [Abstract][Full Text] [Related]
3. ABCG2 null alleles define the Jr(a-) blood group phenotype.
Zelinski T; Coghlan G; Liu XQ; Reid ME
Nat Genet; 2012 Jan; 44(2):131-2. PubMed ID: 22246507
[TBL] [Abstract][Full Text] [Related]
4. A new ABCG2 null allele with a 27-kb deletion including the promoter region causing the Jr(a-) phenotype.
Ogasawara K; Osabe T; Suzuki Y; Tsuneyama H; Isa K; Kawai M; Obara K; Ogiyama Y; Ito S; Uchikawa M; Satake M; Tadokoro K
Transfusion; 2015 Jun; 55(6 Pt 2):1467-71. PubMed ID: 25522810
[TBL] [Abstract][Full Text] [Related]
5. Null alleles of ABCG2 encoding the breast cancer resistance protein define the new blood group system Junior.
Saison C; Helias V; Ballif BA; Peyrard T; Puy H; Miyazaki T; Perrot S; Vayssier-Taussat M; Waldner M; Le Pennec PY; Cartron JP; Arnaud L
Nat Genet; 2012 Jan; 44(2):174-7. PubMed ID: 22246505
[TBL] [Abstract][Full Text] [Related]
6. The JR blood group system: identification of alleles that alter expression.
Hue-Roye K; Zelinski T; Cobaugh A; Lomas-Francis C; Miyazaki T; Tani Y; Westhoff CM; Reid ME
Transfusion; 2013 Nov; 53(11):2710-4. PubMed ID: 23438071
[TBL] [Abstract][Full Text] [Related]
7. An update on the JR blood group system.
Castilho L
Immunohematology; 2019 Jun; 35(2):43-44. PubMed ID: 31246485
[TBL] [Abstract][Full Text] [Related]
8. Hemolytic disease of the newborn due to anti-Jra from a Chinese mother with one novel and one classic heterozygous mutation.
Xiao J; Yang Q; Gao S; Song H; Zhao F; Guo Z; Zhang Y; Zhu Z; Ye L; Xiang D
Transfus Med; 2023 Aug; 33(4):297-305. PubMed ID: 36971189
[TBL] [Abstract][Full Text] [Related]
9. Two novel ABCG2 alleles resulting in a Jr(a-) phenotype.
Berardi P; Cote J; Vege S; Aeschlimann J; Cserti-Gazdewich C; Westhoff CM
Transfusion; 2017 Nov; 57(11):2811-2812. PubMed ID: 28836283
[No Abstract] [Full Text] [Related]
10. Molecular analysis of immunized Jr(a-) or Lan- patients and validation of a high-throughput genotyping assay to screen blood donors for Jr(a-) and Lan- phenotypes.
Haer-Wigman L; Ait Soussan A; Ligthart P; de Haas M; van der Schoot CE
Transfusion; 2014 Jul; 54(7):1836-46. PubMed ID: 24456066
[TBL] [Abstract][Full Text] [Related]
11. Expression levels of ABCG2 on cord red blood cells and study of fetal anemia associated with anti-Jr(a).
Fujita S; Kashiwagi H; Tomimatsu T; Ito S; Mimura K; Kanagawa T; Endo M; Miyoshi T; Okamura Y; Tani Y; Tomiyama Y; Kimura T
Transfusion; 2016 May; 56(5):1171-81. PubMed ID: 26868047
[TBL] [Abstract][Full Text] [Related]
12. Fatal hemolytic disease of the fetus and newborn caused by anti-Jr
Kim MS; Kim JS; Park H; Chung Y; Kim H; Ko DH; Hwang SH; Won HS; Oh HB
Transfus Apher Sci; 2020 Feb; 59(1):102605. PubMed ID: 31324575
[TBL] [Abstract][Full Text] [Related]
13. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).
Doyle L; Ross DD
Oncogene; 2003 Oct; 22(47):7340-58. PubMed ID: 14576842
[TBL] [Abstract][Full Text] [Related]
15. An update to Kidd blood group system.
Hamilton JR
Immunohematology; 2024 Apr; 40(1):28-33. PubMed ID: 38739024
[TBL] [Abstract][Full Text] [Related]
16. Effect of oxygen on multidrug resistance in the first trimester human placenta.
Lye P; Bloise E; Dunk C; Javam M; Gibb W; Lye SJ; Matthews SG
Placenta; 2013 Sep; 34(9):817-23. PubMed ID: 23790363
[TBL] [Abstract][Full Text] [Related]
17. Defining the Jr(a-) phenotype in the Japanese population.
Tanaka M; Kamada I; Takahashi J; Kimura K; Matsukura H; Tani Y
Transfusion; 2014 Feb; 54(2):412-7. PubMed ID: 23713577
[TBL] [Abstract][Full Text] [Related]
18. Case report: massive postpartum transfusion of Jr(a+) red cells in the presence of anti-Jra.
Yuan S; Armour R; Reid A; Abdel-Rahman KF; Rumsey DM; Phillips M; Nester T
Immunohematology; 2005; 21(3):97-101. PubMed ID: 16178666
[TBL] [Abstract][Full Text] [Related]
19. Does anti-Jra cause hemolytic disease of the newborn?
Toy P; Reid M; Lewis T; Ellisor S; Avoy DR
Vox Sang; 1981; 41(1):40-4. PubMed ID: 7324442
[TBL] [Abstract][Full Text] [Related]
20. The LAN blood group system:a review.
Peyrard T
Immunohematology; 2013; 29(4):131-5. PubMed ID: 24689682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
